Abstract
Somatic genetic and epigenetic alterations have been suggested to be crucially involved in development and progression of cancers including prostate cancer (PCa). Epigenetic alterations such as chemical modification of chromatin associated proteins and DNA methylation can largely affect gene expression that may be important for early normal organ development, and also produces favorable conditions for cancer cell formation, growth, and survival. Aberrant DNA methylation (hyper- or hypo-methylation) may lead to chromosomal instability, and transcriptional gene silencing for tumor suppressors or overexpression for oncogenes. Vitamin Bs play important roles in one carbon metabolism that provides critical metabolites for DNA methylation, DNA repair and nucleic acid synthesis. Nutrition uptake and circulating levels of these vitamin Bs as well as genetic polymorphisms of related key enzymes in the one carbon metabolism pathway may govern bioavailability of the metabolites, and therefore to affect the phenotypic changes (e.g., cellular malignancy) via genetic and epigenetic alterations. This article will summarize recent new findings from laboratory, epidemiological or clinical trial studies regarding influence of vitamin B and one carbon metabolism on PCa development or progression.
Keywords: One carbon metabolism, folate, folic acid, DNA methylation, vitamin B6, vitamin B12, SNP, prostate cancer, Vitamin Bs, Carbon Metabolism, Aberrant DNA methylation, cellular malignancy, vitamin B, lung cancer, Androgen ablation, micronutrients, vitamin B2, dihyrofolate reductase, tetrahydrofolic acid, formyl folylpolyglutamates, 5-methyltetrahydrofolic acid, 5-methyl THF, deoxythymidylate, thymidylate synthase, antifolate agents, methotrexate, fluorouracil, hyper-methylation, adenosylhomocysteine, Methyl-Donor Nutrients, hypomethylation, O6-methylguanine-DNA methyltransferase, 8-oxoguanine-DNA glycosylase, 8-oxo-7,8-dihydroguanine, choline and methionine deficient, insulin-like growth factor 2, dimethyl-H3K9, beta-catenin, Alpha-Tocopherol, methylmalonic acid
Mini-Reviews in Medicinal Chemistry
Title: Vitamin Bs, One Carbon Metabolism and Prostate Cancer
Volume: 10 Issue: 14
Author(s): K. V. Donkena, H. Yuan and C. Y.F. Young
Affiliation:
Keywords: One carbon metabolism, folate, folic acid, DNA methylation, vitamin B6, vitamin B12, SNP, prostate cancer, Vitamin Bs, Carbon Metabolism, Aberrant DNA methylation, cellular malignancy, vitamin B, lung cancer, Androgen ablation, micronutrients, vitamin B2, dihyrofolate reductase, tetrahydrofolic acid, formyl folylpolyglutamates, 5-methyltetrahydrofolic acid, 5-methyl THF, deoxythymidylate, thymidylate synthase, antifolate agents, methotrexate, fluorouracil, hyper-methylation, adenosylhomocysteine, Methyl-Donor Nutrients, hypomethylation, O6-methylguanine-DNA methyltransferase, 8-oxoguanine-DNA glycosylase, 8-oxo-7,8-dihydroguanine, choline and methionine deficient, insulin-like growth factor 2, dimethyl-H3K9, beta-catenin, Alpha-Tocopherol, methylmalonic acid
Abstract: Somatic genetic and epigenetic alterations have been suggested to be crucially involved in development and progression of cancers including prostate cancer (PCa). Epigenetic alterations such as chemical modification of chromatin associated proteins and DNA methylation can largely affect gene expression that may be important for early normal organ development, and also produces favorable conditions for cancer cell formation, growth, and survival. Aberrant DNA methylation (hyper- or hypo-methylation) may lead to chromosomal instability, and transcriptional gene silencing for tumor suppressors or overexpression for oncogenes. Vitamin Bs play important roles in one carbon metabolism that provides critical metabolites for DNA methylation, DNA repair and nucleic acid synthesis. Nutrition uptake and circulating levels of these vitamin Bs as well as genetic polymorphisms of related key enzymes in the one carbon metabolism pathway may govern bioavailability of the metabolites, and therefore to affect the phenotypic changes (e.g., cellular malignancy) via genetic and epigenetic alterations. This article will summarize recent new findings from laboratory, epidemiological or clinical trial studies regarding influence of vitamin B and one carbon metabolism on PCa development or progression.
Export Options
About this article
Cite this article as:
V. Donkena K., Yuan H. and Y.F. Young C., Vitamin Bs, One Carbon Metabolism and Prostate Cancer, Mini-Reviews in Medicinal Chemistry 2010; 10 (14) . https://dx.doi.org/10.2174/138955710793564106
DOI https://dx.doi.org/10.2174/138955710793564106 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Drugs and Mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Snapshot of Selenium-enclosed Nanoparticles for the Management of Cancer
Current Pharmaceutical Design The Role of STAT3 Signaling in Different Types of Cancers: A Comprehensive Review
Current Enzyme Inhibition Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
Current Medicinal Chemistry Adrenocortical Crisis Triggered by Levothyroxine in an Unrecognized Autoimmune Polyglandular Syndrome Type-2: A Case Report with Review of the Literature
Current Drug Safety Antidepressants: Current Strategies and Future Opportunities
Current Pharmaceutical Design Conotoxins-New Vistas for Peptide Therapeutics
Current Pharmaceutical Design Inhibition of RNA Virus Infections with Peptide-Conjugated Morpholino Oligomers
Current Pharmaceutical Design The Cancer Preventive Effects of Edible Mushrooms
Anti-Cancer Agents in Medicinal Chemistry Inhibition of STAT Signalling in Bladder Cancer by Diindolylmethane - Relevance to Cell Adhesion, Migration and Proliferation
Current Cancer Drug Targets Editorial [Hot Topic: Novel Anti-Cancer Drugs and Therapeutic Approaches (Executive Editor: E. Bergmann-Leitner)]
Current Pharmaceutical Design Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Current Cancer Drug Targets Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease
Current Molecular Pharmacology Antiproliferative and Antioxidant Potential of Leaf and Leaf Derived Callus Extracts of Aerva lanata (L.) Juss. Ex Schult. Against Human Breast Cancer (MCF-7) Cell Lines
The Natural Products Journal Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Current Cancer Drug Targets Harnessing the Natural Pool of Polyketide and Non-ribosomal Peptide Family: A Route Map towards Novel Drug Development
Current Molecular Pharmacology Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Current Molecular Medicine Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Dendritic Cell-Based Immunotherapy in Thyroid Malignancies
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Synthetic Spirocyclohexadienones as New Anti-Migratory Compounds in Triple- Negative Breast Cancer Cell Migration
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Anti-Proliferative Activity of New Biphenyle-Benzylidenethiazolidine- 2,4-dione Bis-Adducts Containing Various Heterocyclic Cores
Letters in Drug Design & Discovery